Mibavademab
Mibavademab Uses, Dosage, Side Effects, Food Interaction and all others data.
Mibavademab is under investigation in clinical trial NCT04159415 (Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy).
| Trade Name | Mibavademab |
| Generic | Mibavademab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Mibavademab
